By Business/Source
Currency:USD
2025/FY
Stock NameRevenueRatio
Developing innovative therapeutics targeting serious viral diseases72.3M100.00%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States72.3M100.00%